Company intelligence / Profile preview

ABI Life Technologies

Beijing, China

Ownership: Private
Development stage: Other

Overview

ABI Life Technologies is a biotechnology company focused on the development and commercialization of advanced molecular diagnostic solutions. The company specializes in rapid, high-sensitivity testing platforms designed for the detection of infectious diseases and oncology markers. By leveraging proprietary PCR-based technologies, ABI Life aims to provide point-of-care and laboratory-grade diagnostics that improve patient outcomes through faster time-to-result. Their product portfolio includes various diagnostic kits and automated systems tailored for clinical and research environments.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Molecular diagnosticsPCR-based testing
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on ABI Life Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABI Life Technologies.

Explore the full profile